Detailed Information on Publication Record
2018
Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer
REMŠÍK, Ján, Radek FEDR, J. NAVRATIL, Lucia BINÓ, Eva SLABÁKOVÁ et. al.Basic information
Original name
Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer
Authors
REMŠÍK, Ján (703 Slovakia, belonging to the institution), Radek FEDR (203 Czech Republic), J. NAVRATIL, Lucia BINÓ (703 Slovakia), Eva SLABÁKOVÁ (203 Czech Republic), P. FABIAN, M. SVOBODA and Karel SOUČEK (203 Czech Republic, guarantor, belonging to the institution)
Edition
British journal of cancer, London, Nature Publishing Group, 2018, 0007-0920
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10601 Cell biology
Country of publisher
United Kingdom of Great Britain and Northern Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 5.416
RIV identification code
RIV/00216224:14310/18:00106565
Organization unit
Faculty of Science
UT WoS
000427945800020
Keywords in English
breast cancer; epithelial-mesenchymal plasticity; intratumoural heterogeneity; CD9
Tags
International impact, Reviewed
Změněno: 23/4/2024 14:27, Mgr. Michal Petr
Abstract
V originále
Background: The intratumoural heterogeneity, often driven by epithelial-to-mesenchymal transition (EMT), significantly contributes to chemoresistance and disease progression in adenocarcinomas. Methods: We introduced a high-throughput screening platform to identify surface antigens that associate with epithelial-mesenchymal plasticity in well-defined pairs of epithelial cell lines and their mesenchymal counterparts. Using multicolour flow cytometry, we then analysed the expression of 10 most robustly changed antigens and identified a 10-molecule surface signature, in pan-cytokeratin-positive/EpCAM-positive and -negative fractions of dissociated breast tumours. Results: We found that surface CD9, CD29, CD49c, and integrin beta 5 are lost in breast cancer cells that underwent EMT in vivo. The tetraspanin family member CD9 was concordantly downregulated both in vitro and in vivo and associated with epithelial phenotype and favourable prognosis. Conclusions: We propose that overall landscape of 10-molecule surface signature expression reflects the epithelial-mesenchymal plasticity in breast cancer.